A Randomized, Open-label, Multiple Dose, Three-treatment, Three-period, Six-sequence Williams Design to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration in Healthy Volunteers
Latest Information Update: 03 Feb 2016
At a glance
- Drugs Udenafil (Primary) ; Bosentan
- Indications Benign prostatic hyperplasia; Erectile dysfunction; Portal hypertension; Pulmonary arterial hypertension
- Focus Pharmacokinetics
- Sponsors Dong-A Pharmaceutical
- 27 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 31 Aug 2013 New trial record